Risk of Hepatitis B Virus Reactivation in Patients Who Are Hepatitis B Surface Antigen Negative/Antibody to Hepatitis B Core Antigen Positive and the Role of Routine Antiviral Prophylaxis Reply

被引：1
|
作者：
Yeo, Winnie [1 ]
Leung, Nancy W. Y. [2 ]
Chan, Vicky T. C. [1 ]
Chan, Paul K. S. [3 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Alice Ho Mui Ling Nethersole Hosp, Dept Med, Tai Po, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Microbiol, Stanley Ho Ctr Emerging Infect Dis, Sch Publ Hlth,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
THERAPY;
D O I：
10.1200/JCO.2009.21.9881
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2571 / 2572
页数：3
相关论文
共 50 条
  • [1] Risk of Hepatitis B Virus Reactivation in Patients Who Are Hepatitis B Surface Antigen Negative/Antibody to Hepatitis B Core Antigen Positive and the Role of Routine Antiviral Prophylaxis
    Koo, Yu Xuan
    Tan, Daniel S. W.
    Tan, Bee Huat
    Quek, Richard
    Tao, Miriam
    Lim, Soon Thye
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2570 - 2571
  • [2] Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/ hepatitis B core antibody positive and/or hepatitis B surface antibody positive breast cancer patients who receive chemotherapy
    Hattori, M.
    Ito, Y.
    Takahashi, S.
    Fukada, I.
    Iwase, T.
    Iwata, H.
    Hatake, K.
    [J]. CANCER RESEARCH, 2013, 73
  • [3] Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
    Yu Xuan Koo
    Matthew Tay
    Yii Ean Teh
    David Teng
    Daniel S. W. Tan
    Iain B. H. Tan
    David W. M. Tai
    Richard Quek
    Miriam Tao
    Soon Thye Lim
    [J]. Annals of Hematology, 2011, 90 : 1219 - 1223
  • [4] Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
    Koo, Yu Xuan
    Tay, Matthew
    Teh, Yii Ean
    Teng, David
    Tan, Daniel S. W.
    Tan, Iain B. H.
    Tai, David W. M.
    Quek, Richard
    Tao, Miriam
    Lim, Soon Thye
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1219 - 1223
  • [5] Hepatitis B reactivation in patients with hepatitis B core antibody positive and surface antigen negative on immunosuppressants
    Clement Chun-Ho Wu
    Rajneesh Kumar
    [J]. World Journal of Meta-Analysis, 2019, (05) : 209 - 217
  • [6] Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
    Sargin, Zeynep Gok
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2023, 34 (03): : 308 - 309
  • [7] The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy
    Lu, Shasha
    Xu, Yu
    Mu, Qitian
    Cao, Lihong
    Chen, Jian
    Zhu, Zhijuan
    Lou, Yinjun
    Meng, Haitao
    Qian, Wenbin
    Tong, Hongyan
    Mai, Wenyuan
    Huang, Jian
    Yu, Wenjuan
    Zhao, Xiaoying
    Jin, Jie
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 1027 - 1032
  • [8] Is Antibody to Surface Antigen Associated With Hepatitis B Reactivation in Patients With Resolved Hepatitis B? REPLY
    Paul, Sonali
    [J]. HEPATOLOGY, 2017, 66 (04) : 1354 - 1354
  • [9] Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor
    Blaich, Annette
    Manz, Michael
    Dumoulin, Alexis
    Schuettler, Christian G.
    Hirsch, Hans H.
    Gerlich, Wolfram H.
    Frei, Reno
    [J]. TRANSFUSION, 2012, 52 (09) : 1999 - 2006
  • [10] HEPATITIS-B VIRUS-INFECTION HAS AN ETIOLOGICAL ROLE IN CIRRHOTIC-PATIENTS WHO ARE HEPATITIS-B SURFACE-ANTIGEN NEGATIVE BUT POSITIVE FOR ANTIBODY TO HEPATITIS-B SURFACE OR CORE ANTIGEN
    CHUNG, HT
    LAI, CL
    LOK, ASF
    [J]. HEPATOLOGY, 1989, 10 (04) : 577 - 577
12345